CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale President, R&D sold 2,698 shares at $8.85 ($23,877)
- 4 Open-market sale Chief Legal Officer sold 1,638 shares at $8.85 ($14,496)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 86,706 shares at an average $9.12 ($790,923)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Agreement ended
- 4 Grant or award President and CEO acquired 2,108 shares (grant or award)
- 4 Open-market sale President, R&D sold 648 shares at $6.26 ($4,056)
- 4 Open-market sale See remarks sold 245 shares at $6.26 ($1,534)
- 4 Planned sale Chief Financial Officer sold 9,373 shares at an average $6.24 ($58,493)
- 4 Open-market sale Chief Legal Officer sold 295 shares at $6.26 ($1,847)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 42,242 shares (option exercise)
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 28 · 556 filings